U.S. Video

Allergan CEO on the call     Mon, 27 Oct '14 | 9:38 AM ET

CNBC's David Faber reports on comments made by Allergan chairman and CEO David E.I. Pyott on the process of a potential acquisition.

Goldman Sachs' bearish oil forecasts     Mon, 27 Oct '14 | 9:35 AM ET

CNBC's David Faber and Jim Cramer, discuss the weakness in the energy complex.

Melissa Etheridge has a video game?     Fri, 24 Oct '14 | 5:00 PM ET

Melissa Etheridge is hoping her new mobile game "Take My Number" based on her newest record, will prove that gaming can be a platform for distributing and selling music. Here she demos the game with Jane Wells.

Cramer's Mad Dash: Buy BABA     Mon, 27 Oct '14 | 9:23 AM ET

Jim Cramer explains what to watch ahead of the open, including Alibaba and Wayfair.

Jim Cramer

CNBC's Jim Cramer thinks Apple Pay can outrun Rite Aid and CVS, after both companies disabled the service at their stores.

Patent expirations weigh on Merck     Mon, 27 Oct '14 | 9:31 AM ET

The "Squawk on the Street" crew discusses pressures facing Merck in regards to drugs coming off patent, and the play on pharma companies.

Fighting Apple Pay     Mon, 27 Oct '14 | 9:18 AM ET

CNBC's Jim Cramer and David Faber discuss resistance by some retailers on the adoption of Apple Pay. Cramer questions if the companies fighting the payments platform have the wherewithal to defeat Apple.

Apple Pay getting hit by rivals     Mon, 27 Oct '14 | 9:00 AM ET

Just a week old, rivals are popping up and threatening the success of Apple Pay.

CNBC's Jim Cramer and David Faber discuss Goldman Sachs' downgrade of its oil forecast. Cramer explains why he disputes the call.

Pharma fight: What's Allergan worth?     Mon, 27 Oct '14 | 9:08 AM ET

CNBC's David Faber reports Valeant Pharmaceuticals is willing to increase its bid for Allergan to at least $200 a share. Jim Cramer provides insight to litigation against investor Bill Ackman over insider trading

Cramer's stock to watch: Allergan     Mon, 27 Oct '14 | 8:53 AM ET

CNBC's Jim Cramer is watching shares of Allergan, Brazil's stock market and earnings this week.

Geoff Dennis, UBS, shares his thoughts on how President Dilma Rousseff's win will likely impact Brazil's markets.

Melissa Etheridge goes mobile     Mon, 27 Oct '14 | 8:42 AM ET

CNBC's Jane Wells reports Melissa Etheridge is experimenting to see if mobile games can be a new way to distribute music.

Twitter's path to 'tweet' success     Mon, 27 Oct '14 | 8:35 AM ET

Now's a unique opportunity to buy the stock, says Neil Doshi, CRT Capital Group, providing his read on Twitter. Shares are up more than 80% since going public.

CNBC's Meg Tirrell reports NBC News has confirmed a pediatric patient was taken overnight to Bellevue Hospital in New York City with symptoms similar to Ebola.

Check out deer window shopping     Mon, 27 Oct '14 | 8:25 AM ET

A buck crashed through a furniture store's grand opening in Cedar Falls, Iowa but apparently didn't find anything he liked.

Apple Pay problems     Mon, 27 Oct '14 | 8:29 AM ET
Apple Pay on display.

Apple's new mobile payment system is coming under fire from some retailers and competitors, reports CNBC's Mary Thompson.

Checkup on big pharma     Mon, 27 Oct '14 | 8:15 AM ET

Barbara Ryan, FTI Consulting, breaks down the numbers on Merck's quarterly results as the company appears to be reaping the rewards of R&D. Also a look ahead to Pfizer's earnings

While Fundstrat's Thomas Lee and Deutsche Bank's David Bianco agree on the direction of the market, they were at odds, in a CNBC interview, over the impact of falling oil prices.

Tempted by Apple     Mon, 27 Oct '14 | 8:05 AM ET

Kevin Landis, Firsthand Capital Management, shares his thoughts on Apple's valuation. It's the ultimate growth at a reasonable price stock, says Landis.

Titans of tech: Twitter, IBM & Amazon     Mon, 27 Oct '14 | 8:05 AM ET

Kevin Landis, Firsthand Capital Management, discusses the outlook on Twitter, IBM's growth story and Amazon's price war.

I could kick myself over Netflix     Mon, 27 Oct '14 | 8:05 AM ET

Kevin Landis, Firsthand Capital Management, discusses his optimistic outlook on Netflix. Look at this great position they've got, says Landis.

What viewers want     Mon, 27 Oct '14 | 7:43 AM ET

Richard Greenfield, BTIG, weighs in on consolidation in the media sector and the prospects of an unbundled world.

'Dead' money on Wall Street?     Mon, 27 Oct '14 | 7:43 AM ET

Richard Greenfield, BTIG, shares his thoughts on why AMC's record-setting "Walking Dead" series is not rewarding its stock.

Crude oil flirts with $80 level     Mon, 27 Oct '14 | 7:33 AM ET

Matt Smith, Schneider Electric, breaks down the play in the energy complex. And Boris Schlossberg, BK Asset Management, provides his take on German confidence.

Dr. Craig Spencer is at Bellevue Hospital in New York undergoing treatment for Ebola.

CNBC's Meg Tirrell reports the latest details on the condition of Dr. Craig Spencer and the controversy about travel bans and quarantines.

Thomas Lee, Fundstrat Global Advisors, and David Bianco, Deutsche Bank, weigh in on catalysts investors should be watching this week.

The FDA wants more data on the new drug, reports CNBC's Meg Tirrell with the latest details.

Monday morning quarterback     Mon, 27 Oct '14 | 6:52 AM ET

The "Squawk Box" news team and Dave Briggs, NBC Sports, discuss this year's World Series playoff, and week 8 in the NFL.

Key midterm elections to watch     Mon, 27 Oct '14 | 6:36 AM ET

CNBC's John Harwood provides a preview of the upcoming elections. Democrats are holding tough but Republicans have the advantage, reports Harwood.

Contact U.S. Video


    Get the best of CNBC in your inbox

    › Learn More

CNBC TV Worldwide

  • The reality series features the sharks who give budding entrepreneurs the chance to make their dreams come true.

  • “Restaurant Startup” is on a quest to discover, invest in and launch America's next generation of epicurean superstars.

  • CNBC's "American Greed" examines the dark side of the American dream. Some people will do anything for money!